Gene therapy is traditionally considered a treatment modality for genetic diseases and a limited number of complex, life-threatening disorders, such as cancer. However, gene therapy also holds promise as a novel means of treating more mundane conditions, including broken bones and damaged cartilages [1–3]. These injuries frequently present enormous clinical challenges to both orthopedic surgeons and rheumatologists, and can result in considerable human suffering and economic loss.
No takes yet. Share an insight, caveat, or question.
Lieberman et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: